N | R2 | P value | |
---|---|---|---|
Baseline | |||
Dominant genus* (category) | 50 | 0.62 | 0.0001 |
Exacerbations, (N) | 50 | 0.01 | 0.81 |
Hospitalization (yes/no) | 50 | 0.01 | 0.70 |
Calprotectin (μg/g of feces) | 46 | 0.01 | 0.91 |
Days prescribed antibiotic coverage (N) | 50 | 0.01 | 0.73 |
Treatment (LGG or Placebo) | 49 | 0.03 | 0.64 |
12-Month visit | |||
Dominant genus* (category) | 27 | 0.53 | 0.0001 |
Exacerbations, (N) | 19 | 0.18 | 0.003 |
Hospitalization (yes/no) | 19 | 0.13 | 0.02 |
Calprotectin (μg/g of feces) | 23 | 0.09 | 0.048 |
Days prescribed antibiotic coverage (N) | 19 | 0.19 | 0.001 |
Treatment (LGG or Placebo) | 26 | 0.03 | 0.71 |